Vasoprotective effects of lysophosphatidic acid inhibit vascular injury caused by SARS-CoV-2 infection. [PDF]
Muramatsu F +12 more
europepmc +1 more source
Cancer therapy-related cardiotoxicity is associated with distinct alterations of the myocardial lipidome. [PDF]
Braun VM +6 more
europepmc +1 more source
CD97; lysophosphatidic acid receptor 1 (LPAR1; EDG2; LPA1) [PDF]
openaire +1 more source
Multiple LPA<sub>3</sub> Receptor Agonist Binding Sites Evidenced Under Docking and Functional Studies. [PDF]
Solís KH +5 more
europepmc +1 more source
Exogenous phosphatidylserine protects against mesenteric ischemia-reperfusion with associated Akt/mTOR pathway upregulation. [PDF]
Hamaneh AM +9 more
europepmc +1 more source
Comparative Analysis of Lysophosphatidic Acid Levels in Fibromyalgia and Other Painful Conditions in Female Patients. [PDF]
Menezes J +10 more
europepmc +1 more source
Generation of New Knock-Out Mouse Strains of <i>Lysophosphatidic Acid Receptor 1</i>. [PDF]
Antonopoulou G +6 more
europepmc +1 more source
The effect of lysophosphatidic acid on myometrial contractility and the mRNA transcription of its receptors in the myometrium at different stages of endometrosis in mares. [PDF]
Piotrowska-Tomala KK +7 more
europepmc +1 more source
GPR35 mediates monocyte recruitment to the sites of Listeria monocytogenes infection. [PDF]
Okamura Y +10 more
europepmc +1 more source
Molecular Dynamics (MD) Simulation of GPR87-LPA Binding: Therapeutic Implications for Targeted Cancer Treatment. [PDF]
Rani M +5 more
europepmc +1 more source

